EC Clinical and Medical Case Reports

Opinion Volume 6 Issue 1 - 2023

Tangier Disease: The Current Clinical Treatment Approach

Chika J Mbah*

Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Enugu State, Nigeria

*Corresponding Author: Chika J Mbah, Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Enugu State, Nigeria.
Received: November 02, 2022; Published: December 29, 2022



Tangier disease is a rare, autosomal recessive storage disorder of serum lipoprotein metabolism. The disease is named after an island off the coast of Virginia (Tangier island Chesapeake Bay) where the first patients were identified. Esterified cholesterol is found to accumulate in macrophages and Schwann cells of peripheral nerves, plasma cholesterol is observed to be low and plasma high density lipoprotein almost completely absent [1]. The large build up of esterified cholesterol occur in tissues like the arteries, liver, spleen, and tonsils leading to clinical manifestations such as coronary artery diseases, muscle wasting, peripheral neuropathy, reduced visual acuity, hepatomegaly, splenomegaly, lymphadenopathy and enlarged yellow tonsils [2].

Chika J Mbah. Tangier Disease: The Current Clinical Treatment Approach. EC Clinical and Medical Case Reports   6.1 (2023): 88-89.